HYLORIS PHARMACEUTICALS SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.7 EUR | -1.27% |
|
-.--% | -8.24% |
| Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
| Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 353M | - | |||||
| 684B | ||||||
| 568B | ||||||
| 361B | ||||||
| 329B | ||||||
| 284B |
